Constellation Pharmaceuticals (CNST) 10-Q2021 Q1 Quarterly report

Filed: 10 May 21, 6:05am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: aberrant, androgen, antitumor, ARSi, automatic, automatically, baseline, Biden, Bio, Boehringer, bore, CAA, carcinoma, central, cohort, Committee, concept, conditionally, confer, cytokine, demethylase, differentiation, dysfunction, elevated, endometrial, enzymatic, erythroid, Factor, fill, formation, furlough, hematopoietic, hemoglobin, hesitant, histology, IND, inflammatory, Ingelheim, injunction, kinase, kit, landlord, lockdown, lysine, megakaryocyte, mesothelioma, mg, missed, morale, mouse, mutation, nationwide, Nuvation, ovarian, overturning, pelabresib, people, PPACA, proliferation, proof, proper, protein, receptor, recognition, reconsider, repaid, sequester, shut, shutdown, splenomegaly, supplier, suppressed, tasked, trillion, unexpired, urothelial, vivo, Watertown, withdrew

Removed: accelerate, accelerated, acceleration, acting, actively, administering, aim, appeal, applied, approximated, begun, biomarker, Bipartisan, blueprint, branded, Cadillac, capitalization, chamber, charge, clarification, close, cloud, CMS, Codification, codified, collateral, collateralized, comparative, computing, conversion, covenant, custodian, customer, declined, deep, default, deferral, denied, disagree, disposition, distinct, Distinguishing, donut, EHA, electorate, entity, Error, escalation, excise, excluding, expedited, explore, exposing, extendable, extremely, FDARA, fearful, finalizing, flexibility, gap, Goodwill, halted, hand, heard, Hedging, HHS, holding, hole, hosting, implemented, importance, incremental, indefinite, inform, instrument, invest, investigative, irrevocably, Jumpstart, leaving, left, mandatorily, measuring, Minister, narrative, negotiated, neutrality, noncontrolling, nonpublic, October, oppose, opt, outline, oversee, passed, pledge, precedent, prepay, prepayment, presentation, prevailing, proposal, prospectively, protracted, qualification, RBC, Reauthorization, rebate, redeemable, reevaluate, reformed, relaxing, rental, repledge, represented, repurchase, restraining, restrictive, retrospectively, reverse, round, selected, servicing, setup, shortened, showing, software, stay, staying, stratifying, subjecting, sublease, suit, superiority, SVR, TD, temporary, terminating, thereon, TI, Topic, transitional, traveling, UK, unambiguously, unrealized, upfront, visiting, voted, vulnerability

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated CNST transcripts

CNST similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Constellation Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jigar Raythatha, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2021	By:	/s/ Jigar Raythatha
		Jigar Raythatha
		President and Chief Executive Officer
		(Principal Executive Officer)